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Background
The rapid scale-up of antiretroviral treatment (ART) for 
HIV since the mid-2000s has been an unprecedented 
achievement in public health. The rapid expansion of access 
to treatment – mostly through vertical programmes funded 
by international donor organisations (Dieleman et al., 2018) 
– has averted millions of deaths and prevented many 
infections in low- and middle-income countries (LMICs) 
(Granich et al., 2015; Murray et al., 2014; Smith et al., 2014). 
Despite the success of the current HIV response, there are 
three important reasons why now is the time to rethink the 
delivery models for HIV treatment for the coming decades.
First, major global donors are slowly pulling back. The HIV 
epidemic predominantly affects resource-poor communities, 
mostly in sub-Saharan Africa. Here, the lack of sufficient 
health facilities and the push for a rapid scale-up of HIV 
services resulted in the creation of vertical ART delivery 
systems. These services are predominantly funded and 
sustained by international donor organisations, like the US 
President’s Emergency Plan for AIDS Relief (PEPFAR) 
and the Global Fund to Fight AIDS, Tuberculosis and 
Malaria. Yet, while the number of people on lifelong ART 
continues to increase (UNAIDS, 2017), the available funding 
falls short. Although overall health aid is higher than ever 
before (Schäferhoff, Martinez, Ogbuoji, Sabin, & Yamey, 
2019), donor HIV spending in LMICs has declined by more 
than $1 billion annually since 2015 (Dieleman et al., 2018; 
Kates, Wexler, & Lie, 2017). These shortages threaten the 
sustainability of the international AIDS response.
Second, non-communicable diseases (NCDs), such as 
diabetes, cardiovascular diseases and cancer, have been 
recognised as a growing source of morbidity and mortality in 
LMICs with generalised HIV epidemics (Allen et al., 2017). 
As people with HIV are living longer due to successful ART 
(Hontelez et al., 2012), NCDs have become a leading cause 
of comorbidity for this population (Haacker, Bärnighausen, & 
Atun, 2019; Kemp et al., 2018; Osetinsky et al., 2019).
Third, the global health agenda is increasingly pushing for 
a shift from vertical programmes towards more integrated 
service delivery within the general health system. The 
sustainable development goals emphasise targets that call 
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The rapid scale-up of antiretroviral treatment (ART) for HIV since the mid-2000s, mostly through disease-specific 
or “vertical” programmes, has been a highly successful undertaking, which averted millions of deaths and 
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which could be achieved through five categories of delivery innovations: integrating ART (“vertical ART plus”, 
“partially-integrated ART” and “fully-integrated ART”); modifying steps in the ART value chain (“professional 
task-shifted ART”, “people task-shifted ART” and “technology-supported ART”); eliminating steps in the ART 
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for ending the HIV, tuberculosis, and malaria epidemics; 
transforming maternal and child health; tackling the growing 
burden of NCDs; and reaching larger numbers of people for 
universal-test-and-treat programmes, all of which should be 
achieved through universal health coverage (UHC) (Bekker 
et al., 2018; United Nations, 2017).
Financial, epidemiological and political sustainability 
will need to be at the core of every country’s future HIV 
response (Oberth & Whiteside, 2016; Phillips et al., 2015), 
triggering a need for innovative health systems thinking. 
Sustainable delivery models should allow for tailored 
country-owned ART delivery models that aim for overall 
cost reduction while ensuring high quality care, as well as 
reaching people living with HIV that the current programmes 
do not reach – these are important but ambitious demands 
on future ART delivery models.
In this article, we propose twelve models – based on 
five delivery model innovations – for ART delivery, which 
could respond to the current challenges and opportunities. 
First, we suggest integration of ART with other health 
services. Integration can be achieved to different degrees 
– adding health services to vertical ART (model 1), partial
integration of ART with other vertical health programmes
(model 2), or full integration of ART into primary healthcare 
(model 3). Second, we propose modifying one or several 
steps in the healthcare value chain – through task-shifting 
of ART delivery to lower-level health workers (model 4) or to 
patients, family members, or community members (model 5), 
or through ART delivery supported by technology (model 6). 
Third, we describe models where steps in the healthcare 
value chain would be eliminated – through immediate 
ART initiation following a positive HIV test (model 7) or 
less frequent ART delivery for patients who are stable on 
treatment (model 8). The fourth innovation is based on 
using new places for ART delivery, which could be private 
health facilities (model 9), traditional healers (model 10), 
or locations outside the healthcare system (model 11). Of 
course, one important delivery model is the status quo, 
i.e. vertical ART services provided apart from other health
services (model 12). All delivery model innovations need to
be benchmarked against the performance of the status quo,
which over the past two decades has proven to be highly
successful. An overview of the described delivery model
innovations and related ART delivery models is presented
in Figure 1.
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Figure 1: Wheel of ART delivery model innovations
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Integrating ART
This delivery model innovation comprises models where 
ART delivery is offered together with other health services. 
This includes integrating care for other diseases with the 
care already available for HIV patients in the status quo 
delivery models (model 1 – “vertical ART plus”), combining 
different vertical systems like tuberculosis or maternal 
health with HIV care (model 2 – “partially-integrated ART”), 
or full integration of HIV care within the general primary 
healthcare system (model 3 – “fully-integrated ART”). 
These models have the potential to lead to efficiency gains 
for the healthcare system, due to shared use of staff and 
physical resources. Integrated models can also increase 
the efficiency of patients’ healthcare utilisation: for comorbid 
HIV patients, care will be available in one clinic visit rather 
than several visits to different clinics. At the same time, it is 
plausible that integrated care increases average costs per 
treatment, because of diseconomies of scope. Vertical care 
ensures maximal learning and procedural efficiency because 
patients are very similar. Integrated care implies more 
dissimilar patients, which reduces learning effects and the 
potential to optimally prepare and organise the resources for 
care provision. 
Model 1 – “vertical ART plus”
In the vertical ART plus model, ART delivery remains 
separate from the general health system, but other 
health services will be offered at the clinic alongside HIV 
services. Frequent comorbidities of people living with 
HIV are tuberculosis (Diedrich & Flynn, 2011; Oni et al., 
2015), NCDs such as diabetes and hypertension (Oni et 
al., 2015), as well as depression and other mental health 
issues (Nanni, Caruso, Mitchell, Meggiolaro, & Grassi, 
2015). With completely vertical HIV service provision, these 
comorbidities are often neglected, and people living with 
HIV need to visit multiple health facilities to access all the 
required care. Vertical ART plus services could capitalise 
on the foundations built with the HIV response to improve 
the efficiency and coverage of care and treatment of these 
comorbidities. Furthermore, screening might be offered 
along with HIV services, which is already done sometimes 
for cervical cancer in young female HIV patients and for 
the most common NCDs in older HIV patients (Duffy et al., 
2017). Vertical ART plus may be more cost-effective than 
purely vertical services as resources are shared, translating 
to increased technical efficiency (i.e. minimalising staff and 
resources while maximising service delivery) (Duffy et al., 
2017). However, the vertical ART plus model may result in 
inequalities in access to care, as HIV-negative people who 
require healthcare are not covered here and will need to 
seek services elsewhere.
Model 2 – “partially-integrated ART”
This model comprises partial integration of ART delivery 
with other existing vertical healthcare programmes, of which 
well-known examples are integration with programmes for 
tuberculosis (Howard & El-Sadr, 2010; Suthar et al., 2012), 
sexual and reproductive health (Warren et al., 2017), and 
NCDs (Duffy et al., 2017; Kemp et al., 2018). More recently, 
HIV service integration with mental health programmes has 
also been explored (Freeman, Patel, Collins, & Bertolote, 
2005; Kaaya et al., 2013). Generally, this form of integration 
allows for operational efficiency gains (i.e. optimised 
service delivery due to specialised staff and well-functioning 
work flows, for example) and is most beneficial when 
target populations of both programmes largely overlap. 
In contrast to the vertical ART plus model, services are 
not exclusively available for people living with HIV. Partial 
integration of ART delivery with other health programmes 
can be realised at different levels, from complete integration 
of location, resources and personnel to solely linking both 
vertical programmes, through strengthened referral. The 
advantages of this model are highly dependent on the level 
of integration and context. Similar to the vertical ART plus 
model, this model has the potential for technical efficiency 
gains. Depending on the context, also allocative efficiency 
gains (i.e. optimal allocation of services based on the 
patients’ needs) might be achieved. However, this model 
does not entail UHC and thus still produces inequalities in 
access to care.
Model 3 – “fully-integrated ART”
This integration model can be defined as ART service 
provision at the same location and with the same (human) 
resources as primary healthcare (Odeny et al., 2013). 
Decentralised ART delivery allows people to access all types 
of healthcare, regardless of their HIV status, thereby tackling 
issues of inequality and stigma associated with more vertical 
systems (Sweeney et al., 2012). 
Whether efficiency is higher compared to more vertical 
systems will largely depend on the local context and 
disease burden. On the one hand, shared resources and 
shared workload among the staff could enhance technical 
efficiency and allocative efficiency of the general health 
system. Furthermore, due to easier referral and access to 
other health services, uptake of ART will likely increase, 
at a lower cost (Chan et al., 2010). On the other hand, 
diseconomies of scope may result in less efficient ART 
delivery, as heath workers and other personnel now need to 
shift focus between treating a wide variety of patients rather 
than specialising and optimising care for a specific group of 
patients. In addition, in high-burden areas, the high numbers 
of HIV infected people requiring care might overburden the 
health system and crowd-out other patients. Finally, a fully 
integrated ART delivery model might be detrimental for care 
and prevention for specific key populations, such as sex 
workers, injecting drug users, or men who have sex with 
men (MSM). In many cases these – often marginalised – 
populations have poorer access to general healthcare, and 
benefit greatly from specifically tailored services. 
Modifying steps in the ART value chain
This delivery model innovation is aimed at modifying different 
essential steps of the value chain (Porter, 2001) of ART 
delivery to increase and improve delivery while ensuring 
low costs. This can be achieved by shifting the offered HIV 
services to lower health workers (model 4 – “professional 
Bulstra, Hontelez, Ogbuoji & Bärnighausen318
task-shifted ART”), other people or the patients themselves 
(model 5 – “people task-shifted ART”), or technology 
supported ART delivery (model 6 –“technology-supported 
ART”). By bringing services closer to the population, these 
models may increase ART coverage, and could bolster 
retention and adherence to ART at relatively low costs. 
When designed well, this type of innovation might alleviate 
pressure from the busy clinics providing HIV treatment. 
The effects on quality of care and patient satisfaction highly 
depend on the type of model and the specific content and 
context of modification.
Model 4 – “professional task-shifted ART”
Health workers have been one, or the “binding constraint”, 
even early in the history of the ART scale-up in sub-Saharan 
Africa (Bärnighausen, Bloom, & Humair, 2007, 2010, 2016). 
Ever since the introduction of nurse-led treatment initiation 
(Samb et al., 2007), various task-shifting strategies have 
been explored to overcome this constraint and to increase 
the efficiency and sustainability of ART delivery. In the 
professional task-shifted ART model, HIV testing and ART 
delivery are partly shifted from nurses to health extension 
workers or community health workers (CHWs), for example 
through home-based testing or mobile testing (Asiimwe 
et al., 2017; Bemelmans et al., 2014) and CHW-led ART 
delivery (Geldsetzer et al., 2017). Clinics are often busy, 
and task-shifting and task-sharing can reduce the work 
load of highly trained health professionals, allowing them to 
provide other complex and essential care. In addition, costs 
will remain relatively low compared to fully centralised ART 
delivery. Community-based testing and service provision 
increases the number of people reached, that might 
otherwise not know their status or would not have access 
to sufficient treatment (Geldsetzer et al., 2018; Zachariah 
et al., 2009). Professional task-shifting can thus lead to 
higher ART coverage and operational efficiency gains. 
Shifting services to CHWs can be realised in both vertical 
and integrated systems, as CHWs can be associated with 
either specific HIV clinics or the general health system. In 
fact, community-based delivery does not need to be unique 
to HIV, and CHWs may also be able to provide pregnancy 
and maternal care (Geldsetzer et al., 2019; Larson et al., 
2019; Lema et al., 2014), screening for hypertension, and 
distribute chronic medication to those in need, or provide 
counselling on where to access other required health 
services. Nevertheless, specialised HIV doctors and nurses 
will still be essential when dealing with more complex cases, 
such as people with poor viral suppression, resistance, or 
complex comorbidities.
Model 5 – “people task-shifted ART”
People task-shifted ART delivery involves the local 
community or even the patients themselves. For instance, 
HIV-positive peers within the community can bolster linkage, 
retention and adherence to ART through adherence clubs, 
community ART distribution points, or non-traditional 
community-oriented care for patients who are stable on 
treatment (Genberg et al., 2016; Holmes & Sanne, 2015). 
Peer educator-led ART refill groups in South Africa, 
community ART distribution points in the Democratic 
Republic of Congo and patient-led community ART groups 
in Mozambique are other examples of successful “people 
task-shifted ART” (Bemelmans et al., 2014). These initiatives 
enable patients to visit clinics less, saving time and travel 
costs, while peer-groups motivate each other to adhere 
to their medication. As international donor funding for HIV 
continues to decline and the number of HIV infected people 
on ART continues to grow, shifting care to the community or 
the individual is a logical consideration to improve efficiency 
and sustainability of the HIV response, while also freeing-up 
resources for other diseases. However, this model, like other 
task-shifting initiatives, comes with several disadvantages. 
Generally, shifting services away from the clinics will 
challenge quality-control. In addition, bringing care closer 
to home might affect privacy of patients and therewith 
discourage patients from seeking care due to HIV-related 
stigma. 
Model 6 – “technology-supported ART”
Technology-supported ART can include a wide range of 
technologies, all aimed at reducing work, shifting work away 
from health workers or supporting patients or CHWs in their 
routines. Previously explored examples are drone delivery of 
HIV test kits and other medicines in Malawi (Reuters, 2016), 
and mobile fully-equipped ART clinics in Eswatini (MacKellar 
et al., 2018). Another example is the strategic placement of 
electronic pick-up machines, where patients can register with 
a patient-card to receive a tailored treatment package. Also, 
smartphone apps are increasingly developed to stimulate 
adherence and simplify monitoring, for example by providing 
laboratory test results, treatment schemes and information 
on side effects. However, active usage of these apps seems 
challenging, according to a randomised controlled trial 
among HIV patients registered at an urban clinic in South 
Africa (Venter et al., 2018). Tablet-based apps for patient 
registry and monitoring are an example for new technology-
support initiatives for CHWs. Although new technologies 
generally seem promising, in many cases sufficient training 
is needed to use the technologies adequately. Moreover, the 
tools are generally costly, risking theft and damage. 
Eliminating steps in the ART value chain
Eliminating steps in the ART value chain comprises of 
either providing immediate ART after diagnosis (model 7 – 
“immediate ART”) or less frequent ART pick-ups for stable 
patients (model 8 – “less frequent ART pick-up”). Both 
models could be desirable for the patient, while also saving 
costs for the health system due to less frequent visits. The 
main challenge of this innovation lies in sustaining good 
quality of HIV care over time with less frequent patient-
provider interaction.
Model 7 – “immediate ART”
It is important that people who test positive for HIV must 
contact care services in a timely manner. However, 
care-seeking behaviour is highly heterogeneous, leading 
to delay until receiving the first treatment (MacCarthy et 
al., 2015). For instance, if people test positive outside of 
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the central HIV services, for example, through community-
based HIV testing, they are often referred to clinics that 
are busy, not well equipped, and far away. To overcome 
treatment delays, CHWs could be equipped with ART 
supply packages to offer to patients directly. Evidence 
from four trials conducted in African settings suggests that 
treatment outcomes are similar, compared to outcomes of 
linkage to care programmes (Kredo, Adeniyi, Bateganya, 
& Pienaar, 2014). A potential downside of this strategy 
is lack of adherence (Kredo et al., 2014), possibly due to 
insufficient counselling. Also, CHWs would need to have 
additional training to provide patients with all the information 
they need, for example on treatment schemes and important 
side effects. When people are tested in the health clinic, 
a follow-up appointment often needs to be scheduled to 
distribute ART. Here, same-day ART delivery could be a 
solution. A study conducted in an urban setting in Haiti 
showed that same-day ART delivery leads to an increase in 
adherence as well as better treatment outcomes (Koenig et 
al., 2017).
Model 8 –“less frequent ART pick-up”
Currently, many medical protocols require HIV patients to 
visit a clinic every one to three months. This is very time 
consuming and costly both for the patient and the health 
system. Alternative monitoring and ART pick-up schemes 
have been proposed, for example in Uganda, where patients 
are only required to visit their clinic once every six months 
(Nakiwogga-Muwanga et al., 2014). Although this model 
might save costs, the danger lies in the infrequent monitoring 
of patients. Therefore, this model is only suitable for patients 
who are stable on treatment.
Changing ART locations
This delivery model innovation is based on the use of new 
places for ART delivery, such as private health facilities 
(model 9 – “private-sector ART”), traditional healers 
(model 10 – “traditional-sector ART”) or places outside 
of the healthcare system (model 11 – “ART outside the 
health sector”), including supermarkets, train stations and 
faith-based organisations. By offering ART at places that are 
easier to reach, these innovations can increase recruitment, 
adherence and retention to ART. Suitability of these models 
highly depends on the context. Primary challenges that 
should be taken into account when considering these models 
are ensuring quality of care and privacy of the patients.
Model 9 – “private-sector ART”
In the context of a well-developed private healthcare sector, 
the integration of ART delivery into the private sector can be 
considered. This could be the integration of ART delivery into 
the general health services provided by big privately-owned 
hospitals, but also ART distribution via private physicians or 
pharmacies. Although ART delivery might be improved for 
patients from higher socioeconomic classes, this distribution 
method would generally be relatively expensive. Unless 
treatment costs could be covered using alternative financing 
strategies, this model likely leads to increased inequality in 
access to ART, and therefore should not be implemented as 
a stand-alone solution.
Model 10 – “traditional-sector ART”
In some high burden countries, traditional medicine plays a 
central role in society. People infected with HIV might visit 
their traditional healer first, before seeking professional 
care. Traditional healers could be used to deliver ART, 
screen for HIV or do adherence counselling, therewith using 
their (often) trustworthy image and big network within the 
community. However, this model needs to be considered 
with caution. Community healers could have profit motives, 
and generally it would be challenging to guarantee the 
quality of the services being offered. In addition, traditional 
healers follow different believes compared to allopathic 
medicine: not all of them would be open to supporting 
allopathic medicine practices, and they provide care that 
may not be conductive to the clinical success of ART. 
Model 11 – “ART outside the health sector”
Alternatively, ART could be delivered at places outside of 
the health sectors, at public or frequently visited places. 
Suitable places would be supermarkets, train stations and 
faith-based organisations, as well as other places that 
are easy to access for a vast majority of the population. 
However, this type of distribution strategy needs to be very 
well thought out in order to secure the privacy of patients 
and ensure good quality of care. 
Keeping the status quo
Another option is to maintain the status quo, keeping ART 
delivery models as they currently are (model 12 – “vertical 
ART”). In this case, HIV services will continue to be provided 
apart from the general health systems. There are many 
good arguments for this choice. Generally, vertical delivery 
implies high operational efficiency, due to high levels of 
expertise and standardised work flows. Also, the current 
delivery models have proven to be successful, and the risk 
of adapting or changing this model must be considered 
carefully. Furthermore, the current models have already 
evolved and are often well-adapted to local contexts. 
However, solely maintaining this model may not be feasible 
in resource limited contexts. 
Model 12 – “vertical ART”
In vertical systems, experienced doctors, nurses and other 
health workers work exclusively with HIV infected people, 
and therefore likely offer higher quality of care due to 
specialisation while doing their work more efficiently (i.e. 
economies of scale) in high-burden areas (Bärnighausen, 
Bloom, & Humair, 2011; Sweeney et al., 2012). In these 
contexts, this approach allows for possible cost reduction, 
as well as enhanced quality of ART delivery. In contrast, 
a disease-specific service provision model in low-burden 
areas will likely suffer from diseconomies of scale and scope 
due to excess capacity. Therefore – although operational 
efficiency might be high due to specialised personnel, 
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referral chains, and logistics – the technical and allocative 
efficiency of disease-specific service delivery is highly 
dependent on the local disease burden. In addition, disease 
specific models may introduce inequalities in access to care, 
both in low and high-burden settings, as services for other 
diseases may remain inadequate (Bekker et al., 2018; Kim, 
Farmer, & Porter, 2013). HIV patients receiving care at the 
ART clinic might need to seek care for other conditions, such 
as hypertension or diabetes, elsewhere. 
Discussion 
We proposed five categories of “delivery model innovations” 
for ART, translated into twelve concrete ART delivery 
models. None of these proposed models will be a “silver 
bullet” for the world. Rather, suitability of the models will 
highly depend on the epidemic, health systems, political 
and cultural contexts (De Neve et al., 2017). For instance, 
countries with generalised epidemics may continue to 
benefit from a degree of “verticality” in the delivery of ART, 
because in many communities in these countries there are 
sufficiently large numbers of HIV patients to keep vertical 
Table 1: Overview of the definitions and examples of models for ART delivery based on five delivery model innovations
Innovation Delivery model Definition Examples
Integrate with 
other health 
services
Vertical-plus ART Other services are provided 
within vertical ART services
• Anti-hypertensive care, diabetes prevention and other NCD
services provided with ART services in Kenya, Uganda and
Nigeria (Duffy et al., 2017)
• Depression care offered with ART in the Unites States (Bengtson
et al., 2016)
Partially-integrated 
ART
Integration with other vertical 
health services
• Integration with tuberculosis services in sub-Saharan Africa, South
America and Asia (Howard & El-Sadr, 2010; Suthar et al., 2012)
• Integration with sexual and reproductive health (Warren et al.,
2017)
• Integration with NCD services in sub-Saharan Africa (Duffy et al.,
2017; Kemp et al., 2018)
Fully-integrated ART Integration of ART services 
into the general primary 
healthcare system
• Integration of HIV care with primary healthcare services in rural
Kenya (Odeny et al., 2013), and Malawi (Chan et al., 2010)
Modify steps 
in the value 
chain
Professional 
task-shifted ART
Shifting the delivery of ART 
from highly to less trained 
health professionals
• Community health workers delivering ART in Tanzania
(Geldsetzer et al., 2018)
• Community health workers delivering prevention of mother-to-
child transmission services in Tanzania (Naburi et al., 2017)
• Expanding testing and linkage to care through community health
workers in Uganda (Asiimwe et al., 2017), Rwanda and Malawi
(Zachariah et al., 2009)
People task-shifted 
ART
Shifting the delivery of ART 
from healthcare professionals 
to lay people
• Improving adherence trough peer-support among pregnant
women in South Africa (Richter et al., 2014).
• Peer educator-led ART refill groups in South Africa, community
ART distribution points in DRC and patient-led community
ART groups in Mozambique are other examples of successful
task-shifting models (Bemelmans et al., 2014)
Technology-supported 
ART
ART delivery using 
technological innovations
• Drone delivery of HIV test kits in rural Malawi (Reuters, 2016)
• Mobile fully-equipped ART clinics in Eswatini (MacKellar et al.,
2018).
Eliminate 
steps in the 
value chain
Immediate ART ART services provided 
immediately following a 
positive HIV test
• CHWs providing ART packages after HIV testing and counseling,
in several African settings (Kredo et al., 2014)
• Same-day delivery in urban clinics of Haiti (Koenig et al., 2017)
Less frequent ART Decreased frequency of ART 
provision
• Shift from 1-2 to 6 month clinic visits in Uganda (Nakiwogga-
Muwanga et al., 2014)
Use new 
places
Private-sector ART ART delivery in private 
healthcare facilities
• ART delivery at private hospitals, physician practices or
pharmacies
Traditional-sector ART ART delivery supported by 
traditional healers
• ART delivery by traditional healers
ART in places outside 
the health sectors
ART delivery outside of the 
healthcare system
• ART delivery at supermarkets, train stations or faith-based
organisations
Status quo Vertical ART ART delivery remains 
separate from other health 
services, in current places, 
and using current technologies
ART = antiretroviral treatment; CHWs = community health workers; NCDs = non-communicable diseases
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delivery structures fully and constantly occupied. In countries 
with more concentrated epidemics, among key populations 
such as sex workers and MSM for example, specific vertical 
services might be essential to be able to offer specialised 
care, tackle stigma, and promote easier access to health 
care for these vulnerable groups. In contrast, HIV care for 
the general population may be more efficiently provided as 
part of general internal medicine and family health services. 
Moreover, even within regions or countries with similar 
epidemics and health systems contexts, multiple innovations 
might be needed to achieve near-universal ART coverage 
and optimised ART retention and adherence (Bärnighausen, 
Chaiyachati, et al., 2011). Communities living in remote 
areas would, for example, benefit from implementation 
of task-shifted and technology supported ART delivery, 
as this would increase test-and-treat coverage as well as 
decrease travel time and costs for people already receiving 
treatment. For patient groups that are mobile, such as truck 
drivers and seasonal migrants, less frequent ART delivery 
could be a solution to increase adherence. Other important 
facets that need to be taken into account while designing 
the best ART delivery strategies are: the available funding, 
previous successes in the HIV response (of which trends 
in HIV incidence and current ART coverage are important 
markers), burden of other diseases, HIV/AIDS-related 
stigma and political commitment. 
Generally, while it is plausible that delivery model 
innovations can lead to major improvements in the 
effectiveness and efficiency of the HIV treatment cascade, 
we should keep in mind that it is also possible that such 
innovations fail and the envisioned improvements do not 
materialise. The status quo should not be hastily abandoned 
for innovations; careful vetting of novel models through 
implementation science and causal impact evaluations 
should come before any large-scale replacement of the 
current ART delivery programmes.
Optimally tailoring ART delivery to the current financial, 
epidemiological, and political context will likely not only 
require innovations in service delivery, but also in the 
methods used to determine resource allocation. Here 
science can play an important role. First, delivery models 
need to be identified and designed with beneficiaries, 
healthcare providers, and community stakeholders. Based 
on outcomes of ART delivery model comparisons and 
evaluations from various contexts, a framework can be 
designed to support evidence-based decision making. 
Complementary models for people-centred services can be 
developed for each context of the framework. Second, the 
proposed delivery models need to be tested in prototype 
and pilot studies – here science can support, by designing 
studies that allow for causal impact evaluations. 
Also, mathematical modelling can be of value for 
optimising resource allocation for ART. However, these 
models are also largely disease specific, and generally 
ignore the general epidemiological and health system 
context of a specific area. Resource allocation within the 
UHC era will increasingly require multi-disease mathematical 
models that can also capture health system dynamics and 
constraints (Mikkelsen et al., 2017; Osetinsky et al., 2019). 
The proposed delivery model innovations can be utilised 
similarly to reshape other traditionally vertically delivered 
health services, e.g. tuberculosis or family planning services. 
Conclusions and future perspectives
ART delivery model innovations need to be carefully vetted 
and evaluated for their potential to increase ART coverage 
and efficiency. The suitability of the proposed models will 
depend on local and national contexts. Thus, local design 
studies are required to determine the most promising 
delivery model innovations and their precise forms. 
Prototyping and pilot studies are needed to put these models 
to the test before large-scale implementation. The promise of 
ART delivery model innovations is large and implementation 
science, causal evaluation and mathematical modelling 
studies can ensure that it is fulfilled. 
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